Table 20-1
Pharmaceutical and medicine manufacturing — Balance sheet and income statement

Warning View the most recent version.

Archived Content

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please "contact us" to request a format other than those available.

Archived

This page has been archived on the Web.

PDF Symbols  Next table  Previous table

Pharmaceutical and medicine manufacturing — Balance sheet and income statement
  2007 2008 2009 2010 2011
  millions of dollars
Balance sheet  
Assets 19,448 19,675 21,053 22,644 22,740
Cash and deposits 637 884 839 961 778
Accounts receivable and accrued revenue 2,629 2,808 2,871 2,635 2,732
Inventories 3,911 3,257 3,229 2,436 2,340
Investments 7,766 7,748 9,342 12,934 10,956
Investments and accounts with affiliates 7,427 7,407 7,295 10,673 9,045
Portfolio investments 339 341 2,047 2,261 1,911
Loans 8 9 10 14 19
Mortgages 5 5 6 13 12
Non-mortgages 3 4 4 2 7
Bank customers' liabilities under acceptances .. .. .. .. ..
Capital assets, net 2,922 2,862 2,868 2,668 2,654
Other assets 1,574 2,107 1,894 997 3,262
Liabilities 10,565 9,782 9,826 11,634 12,563
Accounts payable and accrued liabilities 4,131 4,886 4,759 5,474 4,956
Loans and accounts with affiliates 5,149 3,714 4,118 3,532 4,290
Borrowings 945 906 1,127 2,013 2,125
Loans and other borrowings 806 782 572 720 882
Bankers' acceptances and paper .. .. .. .. ..
Bonds and debentures 9 8 323 203 105
Mortgages 129 116 232 1,089 1,138
Future income taxes -14 17 -73 105 341
Bank customers' liabilities under acceptances .. .. .. .. ..
Other liabilities 355 259 -105 510 852
Equity 8,883 9,893 11,227 11,010 10,177
Share capital 6,567 7,215 8,299 11,938 10,188
Contributed surplus and other 341 410 522 501 449
Retained earnings 1,975 2,267 2,406 -1,429 -459
Income statement  
Operating revenue 13,143 13,584 12,642 10,583 9,760
Sales of goods and services 12,510 12,838 12,149 10,263 9,058
Interest and dividend revenue (operating) .. .. .. .. ..
Other operating revenue 633 746 493 320 702
Operating expenses 12,214 12,467 11,528 9,549 8,713
Purchased goods, materials and service 9,522 9,672 8,641 7,116 6,280
Wages, salaries and employee benefits 2,280 2,308 2,423 1,981 1,944
Indirect taxes 53 50 39 28 26
Depreciation, depletion and amortization 338 358 359 383 420
Interest expense (operating) .. .. .. .. ..
Other operating expenses 21 80 67 40 43
Operating profit/loss 929 1,117 1,114 1,034 1,047
Interest and dividend revenue 78 56 36 190 15
Interest expense on borrowing 355 228 210 213 254
Gains/losses 1,327 42 -18 257 25
Profit before income tax 1,979 986 923 1,269 834
Income tax 540 265 221 234 269
Equity in affiliates' earnings 14 0 2 61 59
Profit before extraordinary gains 1,453 722 705 1,096 623
Extraordinary gains 12 2 0 -2 0
Net profit 1,465 724 705 1,094 623
Date modified: